Blue Trust’s Cerevel Therapeutics Holdings CERE Stock Holding History
Bought
Maintained
Sold
Blue Trust's CERE Position: Q4 2024 in Review
Blue Trust sold out of Cerevel Therapeutics Holdings (CERE) in Q4 2024, closing a stake of 126 shares — an estimated $5.15K sold.
Blue Trust first reported a position in CERE in Q1 2023 and held it in 5 quarters. The position peaked at $5.15K in Q3 2024. 0 funds tracked by Wall St. Rank hold CERE as of Q4 2024.
- Blue Trust reported no remaining Cerevel Therapeutics Holdings position as of Q4 2024 after selling out during the quarter.
- Blue Trust sold 126 Cerevel Therapeutics Holdings shares in Q4 2024, an estimated $5.15K.
- Blue Trust first reported a position in Cerevel Therapeutics Holdings in Q1 2023 and held it in 5 quarters.
- Blue Trust's Cerevel Therapeutics Holdings position peaked at $5.15K in Q3 2024.
- 0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings as of Q4 2024.
Based on Blue Trust's 13F filing for Q4 2024, filed 22 Jan 2025.